Back

Genetic ablation of neuronal mitochondrial calcium uptake halts Alzheimer's disease progression

Jadiya, P.; Kolmetzky, D. W.; Tomar, D.; Thomas, M.; Cohen, H. M.; Khaledi, S.; Garbincius, J. F.; Hildebrand, A. N.; Elrod, J. W.

2023-10-16 neuroscience
10.1101/2023.10.11.561889 bioRxiv
Show abstract

Loss of mCa2+ efflux capacity contributes to the pathogenesis and progression of Alzheimers disease (AD) by promoting mitochondrial Ca2+ (mCa2+) overload. Here, we utilized loss-of-function genetic mouse models to causally evaluate the role of mCa2+ uptake by conditionally deleting the mitochondrial calcium uniporter channel (mtCU) in a robust mouse model of AD. Loss of neuronal mCa2+ uptake reduced A{beta} and tau-pathology, synaptic dysfunction, and cognitive decline in 3xTg-AD mice. Knockdown of Mcu in an in vitro model of AD significantly reduced matrix Ca2+ content, redox imbalance, and mitochondrial dysfunction. The preservation of mitochondrial function rescued the AD-dependent decline in autophagic capacity and protected neurons against amyloidosis and cell death. This was corroborated by in vivo data showing improved mitochondrial structure and apposition in AD mice with loss of neuronal Mcu. These results suggest that inhibition of neuronal mCa2+ uptake represents a powerful therapeutic target to impede AD progression.

Published in The EMBO Journal (predicted rank #25) · training set

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.